Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX.
Jing LiJingtao LiNa LyuYue MaFei LiuYuqing FengLi YaoZhiyong HouXiaofeng SongHongchuan ZhaoXiaoya LiYingdian WangCheng XiaoBaoli ZhuPublished in: Therapeutic advances in chronic disease (2020)
Overall, our results describe a dynamic process of gut microbiotal changes from the start to the end of FOLFOX treatment, and verified a close relationship between microbiota and treatment outcome. Recognition of the significance of microbiotal intervention before FOLFOX treatment for low-set rectal cancer may improve the effects of these agents.